Tuesday, February 26, 2019

LendingTree Inc (TREE) Q4 2018 Earnings Conference Call Transcript

Logo of jester cap with thought bubble.

Image source: The Motley Fool.

LendingTree Inc  (NASDAQ:TREE)Q4 2018 Earnings Conference CallFeb. 26, 2019, 9:00 a.m. ET

Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

Operator

Good day, ladies and gentlemen, and welcome to the LendingTree Inc. Fourth Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to turn the conference over to your host, Mr. Doug Lebda, Chief Executive Officer. Please go ahead.

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

Thanks, operator, and thank you all for joining the call. I want to use the time this morning to give you my thoughts on the business, run through the progress we're making on key initiatives and provide some context on what we're seeing in the broader market. J.D. will then cover the quarter's financials and our updated guidance.

Before we jump in, let me provide the usual disclaimer. During today's call we may discuss LendingTree's plans, expectations, outlooks or forecasts for future performance. Forward-looking statements are typically preceded by words such as we expect, we believe, we anticipate, or other similar statements. These forward-looking statements are subject to risks and uncertainties and LendingTree's actual results could differ materially from the views expressed today. Many, but not all of the risks we face, are described in LendingTree's periodic reports filed with the SEC. On this call, we will discuss a number of non-GAAP measures and I refer you to today's press release available on our website at investors.lendingtree.com for the comparable GAAP measure, definitions and full reconciliations of non-GAAP measures to GAAP.

With that, let's get into it. Overall, I'm very pleased with this quarter's results and everything we're able to achieve in 2018. This past year, in the face of a very challenging mortgage environment, we continued to execute on our diversification strategy, building out our portfolio of brands and businesses. We acquired four solid companies that are generating significant synergies and economies of scale. Most importantly, we entered the insurance space with a premier insurance platform, significantly expanding our total addressable market.

With insurance, we now have five primary revenue drivers and each could prospectively contribute roughly 20% of total revenue. In addition, we've made a lot of progress on My LendingTree and have laid the ground work that will enable us to begin investing in off-line marketing profitably and at scale. Overall, it was a great year.

And now I'd like to walk through some of the highlights and current trends in our different product categories. Let's start with mortgage. There are two major points to remember from our strategic approach to mortgage last year. First, our focus has been on the health of the lenders on the LendingTree network, particularly as margins decreased late in the year and in the middle of the year as well. The consequence of focusing on lender health is that our revenue in mortgage throughout 2018 was not as strong as it otherwise would have been.

Second, recall that we indicated at the end of Q3 that we were starting to see some improvement on the cost side of the equation with improving unit economics in mortgage. That cost trend held in Q4. And while we did not see the robust revenue in mortgage, the contribution to the overall business improved. This enabled us to manage the business for VMD, as we always do, through this challenging period. As evidence, while revenue declined 31% year-on-year and 16% sequentially, we were actually able to improve VMD for mortgage by more than 3% in the quarter. Mortgage was actually our second largest contributor in terms of VMD in the quarter.

As we enter 2019, we are optimistic about the macro environment, the drop in rates combined with reduced capacity and competition provides a bit of external stimulus to lender profitability. We are optimistic that this will help us return to sequential growth in mortgage. Additionally, we're continuing to make progress on our initiatives into new mortgage experience. Sushil Sharma, our new Head of Product, has infused new energy, ideas and execution into the team. Today we're incredibly focused on user segmentation and dynamically routing consumers to the right lender and also ongoing CRM engagement.

The takeaway on the new mortgage experience is that we continue to learn and iterate every day, but importantly, we're in the fortunate position of being able to get this right for consumers, lenders, and LendingTree and we're well on our way.

Next, let's talk about insurance. As we discussed on our December Investor Day, insurance is a huge category with over $9 billion in advertising spend and $4 billion or more from the top 10 players alone. We did a lot of homework prior to aligning with QuoteWizard and we are thrilled to have found the team that can maximize this great market opportunity. After the first few months, it is very evident to me that we found the right team. They've built a comprehensive insurance business, helping carriers and agents with a full spectrum of marketing products. We acquired long-standing relationships as well as proprietary technology platforms that may actually eventually help the broader LendingTree business.

Lastly, the QuoteWizard team approaches the business just like we do at LendingTree, with the long-term growth mindset, but a commitment to profitability. The early signs of progress are very encouraging with QuoteWizard, outperformed our expectations during November and December. Most exciting is the fact that we've been able to layer on the recently acquired ValuePenguin content business. As a reminder, approximately 80% of ValuePenguin's business is insurance. Over time we are very confident that QuoteWizard clients will benefit from ValuePenguin's high-quality content. Initial signs of receptivity are very encouraging and ahead of our plan.

In credit card, we saw an expected seasonal slowdown in traffic and issuer demand as is typical in the fourth quarter, but we also saw a promising uptick in January, following the traditional seasonal pattern. That said, we see several growth opportunities in the card business, as we ramp into 2019. One is clearly our brand investment in CompareCards. As we highlighted at Investor Day, we're now running CompareCards specific TV ads. The early results from those ads have been exceptional as direct site visits to CompareCards were up more than threefold year-on-year in the month of January and branded search traffic was up a remarkable fivefold. Also as we've spoken about before, there is tremendous opportunity to optimize the credit card business across the My LendingTree platform. Although, we're still in the early stages of that optimization with credit card revenue through My LendingTree in 2018 less than $1 million, we have already generated $600,000 in January and we're confident that those efforts can provide sustained growth throughout 2019.

Speaking of My LendingTree, I'm really excited by our progress overall. Revenue contribution from My LendingTree increased 40% year-over-year and we currently have four products within the logged-in experience that have seen at least double-digit year-over-year growth. Our improved app has been performing exceptionally well with app installs growing 124% year-over-year and active app users up 130% year-over-year. Cumulatively, we now have 10.5 million consumers on My LendingTree. Additionally, we have completed several partner integrations with a handful of major deals in the pipeline. We're looking forward to sharing more information about these partnerships over the next few months.

Personal loans, we continue to see strong growth. The sequential pattern reflected typical fourth quarter seasonality, but we were happy that we were able to grow revenue 32% year-over-year, capping off an exceptional year for personal loans at 52% revenue growth for the full year 2018. Given the numerous acquisitions we've completed over the last several years, it's easy to forget that our personal loans business is entirely homegrown. I'm incredibly proud of the personal loans business and the team behind it.

As we move forward, we have a number of important initiatives in personal loans. First, we are focused on expanding the capacity of our network. Second, we are working to redefine the offer experience and better educate the consumer.

Third, we are integrating our personal loans business with a recently expanded credit services platform. And lastly, we are iterating on various machine learning models to better match lenders and borrowers, making our network more efficient.

Before I hand it over to J.D. to walk you through the numbers, I want to call attention to a few other areas of the business. In deposits, which continues to perform well, we now have roughly 5 times as many banks on the roster, compared to when we first acquired the business and we're continuing to hear very good feedback from our partners.

Small business is also doing well, as we're experiencing increased bidding, which translates to higher RPLs. In addition, renewals are becoming an increasing important -- increasingly important component of this business, generating a recurring revenue stream and helping to drive higher margins, which is a trend we expect to continue. Compared to Q4 2017, revenue from small business has increased 104%.

We're also beginning to see real traction in SEO, with meaningful growth across multiple brands and product categories. DepositAccounts and MagnifyMoney have both doubled their revenue since we acquired the brands in 2017. And through our centralized SEO function, we're becoming a scale player in the content transaction model space.

Our investment in offline advertising is also resulting in lift across a number of channels, including direct traffic, branded SEM and SEO. We're seeing a 40% year-over-year increase in direct-to-site loan request, a 43% lift in branded SEM loan request and a 17% increase in loan request from SEO channels. Additionally, we will be launching several new TV spots over the next few weeks, focusing on a variety of different loan and credit products and we'll be able to share more of that information with you on our next earnings call.

Now, I'd like to turn it over to J.D. to take you through our financial performance and updated guidance.

J.D. Moriarty -- Chief Financial Officer

Thanks, Doug, and thank you all for joining the call this morning. I'll take a few minutes to provide thoughts on our financial performance in the fourth quarter, our updated guidance for full year 2019 and our newly introduced guidance for the first quarter.

In aggregate, our portfolio of businesses performed very well in the fourth quarter and set us up with nice momentum heading into 2019. Thanks to the ongoing diversification of the business and flexibility in our model, we continue to successfully navigate significant headwinds in our mortgage business to once again deliver variable marketing margin and adjusted EBITDA growth of greater than 30%.

Total revenue in the quarter of $202.7 million was up 26% over the fourth quarter of 2017. As part of that, non-mortgage revenue grew 67% year-on-year to $156 million and represented 77% of total revenue. The newly acquired QuoteWizard business, which closed on October 31, finished the year nicely, contributing $31.3 million of revenue to that total.

But it's also worth highlighting that excluding that benefit from QuoteWizard, non-mortgage revenue would have growth 34% compared to last year. Strength in non-mortgage was once again driven by personal loan revenue, which grew 32% year-on-year to $33.5 million. And we continue to be really encouraged by the progress we're seeing in some of our smaller non-mortgage categories, like small business lending and deposits, which are emerging as real contributors to revenue and margin growth.

In total, our business generated a record $78.6 million of variable marketing margin in the fourth quarter, up 40% year-over-year. Beneath variable marketing margin, as we scale the business, we are going through a rebasing of our fixed cost structure with the addition of a meaningful number of employees last year, both through strategic hiring and through the four acquisitions we completed.

Our operating expense base has increased materially from Q3 to Q4 and will increase substantially again in the first quarter before stabilizing. I'll discuss those trends in a moment along with our forward outlook.

But including the increased Q4 OpEx, adjusted EBITDA in the quarter grew 33% year-over-year to $39.4 million, squarely inside the guidance range we provided last November. In terms of GAAP profitability, we reported net income from continuing operations of $251,000. Our GAAP results in Q4 were adversely affected by a few items, primarily related to the QuoteWizard transaction.

We recorded $4.9 million of expense associated with deal fees. We also recorded the charge of $9.6 million related to increases in the carrying value of earn-out obligations. And the amortization of intangibles increased to $9.8 million in the quarter. In normalizing for these and other expenses, adjusted net income in the quarter was $16.7 million, or $1.22 per diluted share. Adjusted net income per share was up 45% over the prior year.

Now let's shift gears from Q4 to our updated guidance. For the full year, we're increasing our outlook to primarily reflect the ValuePenguin acquisition, which closed on January 10. For the year, revenue is now expected in the range of $1.010 billion to $1.045 billion. VMM is expected to be $385 million to $400 million and adjusted EBITDA is raised to $205 million to $215 million from the prior range of $195 million to $205 million.

Finally, let me provide some context for our newly introduced Q1 guidance. We anticipate revenue of $235 million to $245 million, up 30% to 35% from Q1 of 2018. We anticipate VMM of $82 million to $86 million, which represents approximately 35% variable marketing margin at the midpoint.

You will notice that that margin profile is slightly lower than where it has been in the last few quarters and that's largely attributable to the increased offline brand investment we spoke to at length during our Investor Day.

During Q1, we intend to spend at least $10 million on broadcast and radio brand advertising, compared to the approximately $6 million spent in all of 2018. The early indicators of performance on that spend are very positive, as Doug pointed out. But keep in mind we expect to reap most of the benefit of that investment over an extended period of time as opposed to in-quarter.

Similarly, we expect adjusted EBITDA to be in the range of $37 million to $40 million for Q1. In addition to the significantly increased brand spend, this guidance implies the increased operating expense that I mentioned earlier, resulting in a lower adjusted EBITDA margin than where we've been running.

We're now bearing a full quarter of the QuoteWizard expense base and we have several other expense items that tend to be seasonally higher in the first quarter. It's common for our expense base to step up materially from Q1 to Q4 and then stabilize.

While we've certainly added substantially to our team in portfolio businesses over the last two years, our hiring plans in 2019 are significantly more muted and growth in operating expense throughout the year will be dramatically slower. We are confident that our operating base will demonstrate considerable leverage as revenue scales throughout the remainder of the year.

Now, before opening up to questions, I'd just like to echo Doug's view that we are thrilled with the strategic steps that we took in 2018 and the setup for our increasingly resilient business as we head into 2019. We feel very good about our ability to hit in the goals we laid out for our Board and our shareholders just a few months ago.

With that operator, we can turn to Q&A.

Questions and Answers:

Operator

Thank you. (Operator Instructions) Our first question comes from the line of Mark Mahaney with RBC Capital Markets. Your line is open, please go ahead.

Mark Mahaney -- RBC Capital Markets -- Analyst

Great. Thanks. Maybe two questions. J.D. you talked about the increasing guidance being largely due to the ValuePenguin acquisition. Maybe just quantify that a little bit more. Is that -- was it pretty much entirely due to that? And what else would have caused the increase in guidance?

And then Doug you talked about kind of returning to sequential growth in mortgage. And I don't know if you want to put a fine print around that like is that in the March quarter? Is that some time in 2019? Just any way to ring fence that would be appreciated. Thank you.

J.D. Moriarty -- Chief Financial Officer

Sure Mark, its J.D. I'll start. The increasing -- any time that we are up in guidance, it's reflective of the market environment that we're in. But if you look back at our history since we started doing our December Investor Day, we've been disciplined about wanting to have a full picture of the business. Meaning we just gave a guide in December.

To up that guide and have some material change from December to February, that's not our practice. So, this guide is reflective of ValuePenguin primarily. And obviously, we have to assess the business, but it's predominantly ValuePenguin. And we're really encouraged by the early signs there, but that's predominantly it.

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

And on the mortgage question, we would expect to see sequential growth from Q4 to Q1 clearly and expect and hope that to continue throughout the year. So, yes, definitely in the March quarter.

One thing I just want to highlight for everybody. Keep in mind that we -- and I talked about it in my remarks, but we always manage the business to VMM. So, in a quarter like Q4, just like it was in Q3, you can't profitably spend on marketing, for example, or for refinance if most consumers aren't going to have a benefit and so you pull back on your marketing that's why the VMM continue to rise in Q1 because the brand spend is working and obviously some seasonal effects and little bit better on the lender health side plus we're continuing to make improvements to our experience. I think we're just going to start seeing it right now.

Mark Mahaney -- RBC Capital Markets -- Analyst

Okay. Thanks Doug, thanks J.D.

Operator

Thank you. And our next question comes from the line of John Campbell with Stephen. Your line is open, please go ahead.

John Campbell -- Stephen -- Analyst

Hey guys, good morning.

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

Good morning. Hey John.

John Campbell -- Stephen -- Analyst

I know it's too early but can you guys maybe talk a little bit about just kind of the early revenue synergies you're seeing from QuoteWizard. And then any color around the QuoteWizard and My LendingTree relationship and how much integration you guys expect over the kind of near to medium term?

J.D. Moriarty -- Chief Financial Officer

Yes absolutely. I think there are two ways to look at it John. First of all, there's the initial premise on which we did the QuoteWizard transaction which is to say that like the other companies that we've acquired, QuoteWizard should benefit by being part of the LendingTree platform. There are just clear traffic advantages and we're tracking synergies there.

We're already seeing early wins just in terms of CRM benefits. But the strategy that we've employed with our acquisitions is to diversify their marketing mix, right? And so we got the unique opportunity with ValuePenguin to do that early in the curve of QuoteWizard being part of LendingTree.

And so the initial signs in terms of QuoteWizard's clients, right keep in mind, you've got 10 years of building out relationships with carriers and agents the early signs in terms of their receptivity to the ValuePenguin content are really encouraging.

So, we feel very good about insurance. We feel great about the integration of QuoteWizard with LendingTree and we feel particularly good about essentially the catalyst that ValuePenguin will give QuoteWizard in the marketplace with carriers and agents.

So, I just think the way to think about it is we were able to do this and achieve this diversification of marketing mix earlier for QuoteWizard than, for instance, we were able to organically with CompareCards.

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

And on the My LendingTree integration I want to highlight that the biggest opportunity is actually in card. If you looked at say like Credit Karma, for example, they probably have over 75% of their monetization coming from credit cards and on My LendingTree it's in the single-digit percentages. But as we integrate that as we get the payouts equal et cetera that's the big opportunity and that's well under way.

QuoteWizard -- having insurance inside of My LendingTree will absolutely happen this year. The challenge in insurance as everybody knows you can't necessarily get bindable quotes. So, the integration of it and making sure it's right for the consumer and they get approved is a little more complicated but we absolutely expect to do it.

John Campbell -- Stephen -- Analyst

Okay. Thanks. And then on mortgage Doug you mentioned the expectation for kind of the sequential acceleration in 1Q. I mean obviously you guys have seen about two-thirds of the quarter already. Rates backed up. I'm guessing you guys probably got a little bit of a lift there.

Just curious about how much of the mortgage rebound kind of confidence has been I guess already seen versus what you guys expect to see through maybe a seasonally stronger March?

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

Do you want to start now at it?

J.D. Moriarty -- Chief Financial Officer

Yes sure. So, John, I think on mortgage we get a lot of questions here just because of the shift in the rate environment. And I think what I would remind everybody is it takes a little while for these things to play out and it's usually a reflection of kind of the status of our lenders.

So, this is certainly a better macro environment. Our goal is to return to sequential growth throughout the year. But given the difficult comp that we have in Q1, obviously, that informed our guide that mortgage throughout the year could be in aggregate down 5% to 15%.

Now, we've obviously got this better rate environment. It is not -- we are not yet to the point of go-go refi environment, but we do have a rate environment where we're closer to a scenario where more Americans can benefit from a refinance. So, that's an important fact.

What we're really excited about is that this rate environment coupled with reduced competition and capacity is an external stimulus as Doug said to lender health. And you can see that if you look at gain on sale margins for lenders, that's a good sign.

Now, we spent the back half of last year kind of solving for a manageable cost per funded loan and we think we got through that period. And now we just want to execute in mortgage the strategic steps that Doug is talking about and we think we have a better backdrop to do that, but we're only two months into that backdrop. And so it would be premature to suddenly call it a totally different mortgage environment, but we're certainly encouraged.

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

And just to add on a couple of things just to remind everybody about how this works, so particularly in mortgage, you're always playing off the supply and demand of lenders. And I don't -- I want to make sure every -- like in years past, when we said, hey, when the lenders bid up the value of LendingTree leads, when their volume gets tight, it's true. But remember it's only up until the point that they can't make money and that was what we were experiencing really in Q3 and Q4. So then you pull back on your advertising spend. J.D. hit the word consumer benefit. So not only can lenders not make money in that environment, however, consumers also don't get a benefit from refinancing because rates aren't that much better.

And so, therefore, you've got a lot of leads going to lenders that aren't then able to close. And with the improvement in consumer benefit and with the improvement in overall lender health, you move that back to more of a normalized environment. But the great thing I will say about our mortgage business is, we've proven it now that it will grow VMD in any rate environment short of a 2007 event.

John Campbell -- Stephen -- Analyst

Absolutely. Make sense. Thanks, guys.

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

Thanks, John.

Operator

Thank you. And our next question comes from the line of Jed Kelly with Oppenheimer. Your line is open. Please go ahead.

Jed Kelly -- Oppenheimer -- Analyst

Great. Thanks for taking my question. You said cards were growing $600,000 monthly in January through My LendingTree versus $1 million last year. What's driving that? Is that economics, or is that volume?

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

So it's getting the integration inside of My LendingTree and getting -- and also getting your payouts higher. So, for example, if you think about -- and it also -- I'll give you a very simple example, if you could alert a customer about five different things to save the money, but you sort of have to prioritize, when we didn't have as many lenders on the credit card network and LendingTree was getting substantially lower payouts than CompareCards was, you were showing more consumers personal loans. Now that that credit card network has gotten richer, now that we've made the technology better, that credit card monetization should go up and continue to go up. It really should be the easiest and most natural product to sell to a consumer inside of My LendingTree. And because we were late in cards, we're late in moving it over. But it's a huge upside for that business.

J.D. Moriarty -- Chief Financial Officer

And Jed, it's J.D. Let me just step back on card for a second, which is, when you look at the comparison from Q4 of 2017 to Q4 of 2018 you got to recognize that we were in a pretty different card environment in terms of balance transfer cards and payouts. And so our goal through 2018 which was a much more challenging environment for card simply to control the things we control. So integration with My LendingTree was one of the big initiatives we talked about at the end of last year. We're finally starting to see some benefit there. But some of that is integration with the platform. Some of that's just winning over issuers. And so we are trying to expand our card network. We're trying to expand it in terms of the number of issuers that interact with us.

And we made progress throughout the year in a pretty difficult environment for card. So that macro environment is still challenging, but we feel really good about the tracks that we laid throughout 2018. And if we get back to a better card environment My LendingTree will be part of it. You see us spending brand dollars to direct people to the CompareCards brand. We feel really good about the investments we've made in card despite the fact that the growth Q4 to Q4 feels somewhat anemic. The reality is we feel good about card and we think integrating with My LendingTree is one of the really good opportunities.

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

And just to add onto that a little bit. It just sort of hit me that card operates in some ways very similar to mortgage, because what you have underlying there is a mix shift issue. So for a balance transfer card, when lenders want to put those on the books, obviously, consumers have a lot of benefit. You move your money from this card to that card. You save money in your interest rate. It's a piece of cake. And therefore lenders will pay us more because those have a higher conversion rate. When you've already got a travel card in your wallet and you come to a site and you look for another travel card, the conversion rates are going to be lower and therefore the payouts are lower. So there's an underlying mix difference that we just need to make sure we all tease out but the credit card business is doing very well.

Jed Kelly -- Oppenheimer -- Analyst

And then, I guess, one of your larger digital mortgage partners just closed a pretty large funding round and another one of your larger traditional mortgage partners just announced they're making progress with their digital mortgage initiatives. Are sort of some of the initiatives your partners are making can that accelerate the deployment of RULO?

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

Yes and the answer is, yes, because the underlying shift as you -- among the many changes we're looking at making in the mortgage experience and I don't want to just hinge it on any one particular thing because we've really expanded the mortgage initiative to be looking at CRM, to be looking at the selection or the different ways you select in different channels. For example, I won't bore you with all of that and now I just blanked on your question. What was that?

J.D. Moriarty -- Chief Financial Officer

Digital mortgage.

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

Oh, digital mortgage, yes. So, yes, anything that improves the conversion rates in a mortgage absolutely accrues to the benefit of LendingTree whether it's in a selection-based model or not, but all of that helps. The real key is to get -- be able to get the data from the lenders and that's what we're working on now so that we know once the consumer's gone to you, as a lender, what happened to it. Did they get approved? Did they change their mind? Like over that month and month and month period of time that it could be we need to do much, much better with CRM. And anything digitizing it definitely helps.

The other area that helps is today in traditional lead generation on the Internet in mortgage, you've got highly trained loan officers, who are very good at selling you and calling you repeatedly. Some people love it. Some people don't. With -- in a more of an automated fashion with digital mortgage, you don't need those high labor costs. And I think that's what Better and others have shown. And even if you look at the loanDepots and the Quicken, they're building digital mortgage divisions inside of those businesses. So, yes, it definitely helps.

Jed Kelly -- Oppenheimer -- Analyst

Thank you.

Operator

Thank you. And our next question comes from the line of Stephen Sheldon with William Blair. Your line is open. Please go ahead.

Stephen Sheldon -- William Blair -- Analyst

Hi. Good morning. I guess just first back on credit cards, you saw a little bit of year-over-year deceleration in the fourth quarter and talked about a normal seasonal uptick in January. So just curious what the trends looked like throughout the fourth quarter on kind of a year-over-year basis and into January and maybe your optimism about continuing to see revenue growth improve in that business throughout 2019 especially with better My LendingTree integration.

J.D. Moriarty -- Chief Financial Officer

Yes. So, Stephen, it's J.D. It's really about the mix in the network. And what we're seeing is it's not just our network. That's true of all of our competition in card. There's not -- in the various networks that are out there, there are not a lot of balance transfer priorities among card issuers right now and so the payout environment is not what it was in 2017.

So we don't yet see signs of that changing. So we're trying to focus on the things that we can control like My LendingTree, like expanding our lender -- pardon me, our issuer network. But we don't yet see a big shift back toward balance transfer cards at this point. We just haven't seen any evidence of it.

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

The credit card business, as we all know, works very similar to a search engine. So as J.D. said, the more lenders you have, it's that depth of coverage so that every customer coming in can get multiple options from multiple issuers.

And then, it's also not just the number of lenders, but also the number of cards that they have. That would be similar to like how many keywords that you're bidding on in Google. And then obviously, the monetization and that comes back to conversion rates.

And we're making good progress across all of those and then we can invest in the marketing. If you see us able to do TV advertising against the CompareCards brand, that's a very good I think underlying indication of the health of that business.

Stephen Sheldon -- William Blair -- Analyst

Got it. That's helpful. And that kind of leads into the second question. You provided some really good detail on the brand marketing plan in December, but I think it also allowed you some flexibility on which products to highlight.

So I think you talked about campaigns focused on CompareCards and QuoteWizard. And I guess now that we're a few months into the year, any commentary you can provide on where the brand marketing focus has been and which products have maybe been highlighted more or less relative to your initial plan.

J.D. Moriarty -- Chief Financial Officer

Sure. The focus in January was largely card and personal loan. There's also an omnibus overall LendingTree campaign. There is not yet a QuoteWizard campaign. And as Doug pointed out, the initial signs of lift have been very encouraging in both card and PL in terms of driving revenue there. Now, again, it's not all in-period.

And what's also really interesting is, we have certain businesses that are drafting off of that. So our credit services business, for instance, has benefited very clearly from the spend on personal loans. And so, that's the benefit of the platform.

But one month -- most of that spend was in January. We're being a lot more -- much more deliberate throughout the year as to which months we know consumers will be more responsive and where the payouts determine -- or where the payouts justify the spend. But the evidence in January was really encouraging.

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

And the only other thing I would add is, last year we really got tight through a lot of offline testing on our metrics on where we thought the numbers needed to be, so we could start this campaign this year. But it's always a white-knuckle ride when you actually buy the media. And the good news is, that it's working at least according to plan and actually a little bit better. So that's very, very encouraging when we can be doing profitable off-line spending, because we can scale into that.

Stephen Sheldon -- William Blair -- Analyst

Great. Thank you.

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

Thank you.

Operator

Thank you. Our next question comes from the line of Hamed Khorsand with BWS Financial. Your line is open. Please go ahead.

Hamed Khorsand -- BWS Financial -- Analyst

Hi. Good morning. Could you guys talk about this ad reselling that you took out from the VMD line? And I thought this was going to be a one-time event. It seemed like you guys accelerated in Q4. And also could you comment on why you're leaving that in adjusted EBITDA? I mean, I can understand that's in EBITDA, but why adjusted since it's supposed to be a one-time event?

J.D. Moriarty -- Chief Financial Officer

Well, no, we don't look at it as a one-time event. Strategically, we know that having that -- those placements is helpful to us strategically. It has helped our card business over time and a number of our businesses. And so, first place is obviously to have it facilitate a LendingTree business, OK? But we also want you to recognize what it is. It's ad selling.

It was never intended to be one-time and we did not drive it intentionally in the fourth quarter. We strategically have that capacity to drive our own businesses from a marketing perspective. And periodically, Hamed, we -- it is going to make more sense to sell it to another advertiser than it's going to make sense to support a LendingTree business. And so, when you see it show up in that line item, that's what it is.

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

And even -- and we're calling this out. I think for every Internet company, this is a fairly typical thing. You buy media. You run your own ads. If your ads aren't profitable at any day, week, month, you basically fill it in, because you don't want to just lose the money with third parties. It's a very easy non-complicated thing. And it's not a strategic part of our business, nor is it high-margin. It basically makes an ad buy profitable, because you can monetize more the eyeballs.

Hamed Khorsand -- BWS Financial -- Analyst

Okay. And then, well, I mean, last quarter you were saying that this was going to be a one-time event. Now, it's becoming regular. So that's why I'm asking the question.

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

No, I don't believe we -- if I said one-time, I would -- I don't -- then J.D. just corrected that record. I don't believe we ever said it was one-time. It's just it is what it is. It'll always be there and be small and be very small margin.

J.D. Moriarty -- Chief Financial Officer

And strategically having those placements, Hamed, is helpful to us. But as Doug points out, flexibility in the model is key. And just as we want to align our marketing spend with the revenue opportunity, this enables us to do that and maximize it.

Hamed Khorsand -- BWS Financial -- Analyst

Okay. And then, could you just talk about the ad spend, how you're going about it in Q1? Do you think that the ad spend in Q1 translates into accelerated EBITDA margin growth throughout the rest of the year?

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

I will leave the numbers to J.D. in terms of the margin percentages, et cetera. And as you know, we always like to focus on dollars, not percentages. But we can see, based on all the modeling we did last year, it's called attribution modeling, where given a certain amount of offline media that over a period of time you get an initial burst, but it -- and then it continues for a certain period of time until it wears out in the market.

And how you buy that media and where you put it, based on all of that, we can see over a period of months that media paying off. It pays off not only in people typing in LendingTree into their browser window, but as we -- I think talked about in the last call, many people like to go to Google or another search engine and type in LendingTree. And then you see your traffic grow through there. So you just need to make sure where you spent the money and what its return was.

Hamed Khorsand -- BWS Financial -- Analyst

Great.

J.D. Moriarty -- Chief Financial Officer

And Hamed, I don't have...

Hamed Khorsand -- BWS Financial -- Analyst

Yes, yes. Thank you.

Operator

Thank you. And our next question comes from the line of Nat Schindler with Bank of America Merrill Lynch. Your line is open. Please go ahead.

Nat Schindler -- Bank of America Merrill Lynch -- Analyst

Yeah. Hi, guys. Thanks. This might be similar to one of the earlier questions. But I wanted to go into a little bit about how QuoteWizard integration is going to work for you guys. Do you believe that this business, although significant, is similar, but also more different than earlier acquisitions have been from your business, will have the similar type of organic acceleration within your platform walls when you add the traffic to it?

And what have you seen so far? I know that there is -- there hasn't been much integration in two months in Q4. But in the four months since you've owned it, have you seen much ability to funnel your traffic through the site and really change the trajectory of the QuoteWizard business?

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

So, let me just do the long-term answer first and then J.D. can fill in with any numbers he can. The answer is absolutely yes. We just have to get it right. So, simple terms if somebody is looking for a -- purchasing a house, they obviously are going to need homeowners insurance. Obviously, My LendingTree integration will be there as well.

The thing that I'm hopeful about in insurance and insurance suffers the same challenge in credit card in that the carriers don't give you fully bindable quotes at the point of sale. So, you end up clicking to one insurance carrier. The good news is the QuoteWizard clients are among the biggest and most major insurers in the United States and will -- and as we get bigger and bigger with them, we will be able to work on improved borrower or consumer experiences over time. What you really want to be able to do is be going out and checking with the insurance company if we can save you money on insurance and then only bringing you that offer when we can. That's going to be a few years down the road. And the reason for that is the insurance companies living through the U.K. model. Anything to add J.D.?

J.D. Moriarty -- Chief Financial Officer

Yes, I would just say, Nat, I think the big thing that we learned in insurance over this period of time and I think this will be learned through interacting with the QuoteWizard team during diligence, the carriers are very sophisticated with regard to quality of traffic. And we talked about right pricing as well. And what we're seeing is so far we're benefiting not just in terms of them seeing the power of kind of the QuoteWizard-LendingTree platform and as Doug points out the funnel benefits of homeowners for instance, but we're also -- the carriers are -- we're benefiting in the first period not just in terms of price, but also in terms of volume with the number of the carriers and the agents.

And one of the things that we talked about was the importance of QuoteWizard being a comprehensive platform not a niche insurance business, right. They have scale in calls, in clicks, in leads. They can provide all different marketing products to the carriers and we're really seeing the benefit there.

So, we're pretty confident in the short period of time that QuoteWizard was taking share in the second half of last year. It's probably taking share at a more rapid pace now as part of LendingTree. And then we've given them this great assist with ValuePenguin which would have been at the top of their list in terms acquisitions if they were left stand-alone. Obviously, being part of LendingTree enables them to do that a whole lot easier than as a stand-alone entity.

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

And one specific example is what I alluded to what we're doing with SEO. So our -- the SEO team has been able to now start to ramp up in insurance as well and develop a real expertise in that. So, the more brands we have the -- and that process that these guys have is incredible and we're really able to scale that. And that just adds more traffic to the QuoteWizard platform. It's another reason that we're thrilled that we had to increase our reserves for earn-outs because all of that is just showing that the business is doing better than we expected.

J.D. Moriarty -- Chief Financial Officer

And Nat as you mentioned -- sorry? No, no sorry. I was just going to say I think through the course of the year we will endeavor to kind of give you more of a sense for the draft traffic across businesses. So, QuoteWizard is clearly going to benefit our auto lending business which has been a hard business to scale. And similarly our mortgage business should benefit QuoteWizard on the home side.

And one of the things we're going to endeavor to do is kind of give you more information as to which businesses are benefiting from one another. But we're not quite there yet just a few months in.

Nat Schindler -- Bank of America Merrill Lynch -- Analyst

Okay. And you mentioned someone buying home insurance after buying the home obviously great connect. But most of the insurance that I've seen online has been focused on auto. Can you just do the basic breakdown of QuoteWizard's business auto versus home and life or other products? And on your personal loan business is that significantly related to auto? I didn't really know.

J.D. Moriarty -- Chief Financial Officer

No. So, yes, so -- this is what we referenced at -- at Investor Day, we referenced 79% of the business was auto. That's similar to the industry. But home and MedSup are growing -- home and health are effectively growing very quickly. And there is real interest on the part of the carriers in home which is unique. Just a few years ago that interest was not nearly significant. It was mostly in auto-related business. So, we see a real opportunity in home.

Now as it relates to our personal loan business, no, that's not necessarily driven by auto. No, we're simply saying that somebody who's looking for auto insurance, clearly our auto lending business would benefit from that traffic and that awareness of those consumers.

Our auto lending business has always been challenging to scale because you tend to get disintermediated at the dealer. But clearly we're going to have a traffic advantage with the QuoteWizard presence in auto insurance just awareness of which consumers should be in market for an auto loan.

Nat Schindler -- Bank of America Merrill Lynch -- Analyst

Make sense. Thank you.

J.D. Moriarty -- Chief Financial Officer

Thank you.

Operator

Thank you. And our next question comes from the line of Rob Wildhack with Autonomous. Your line is open, please go ahead.

Robert Wildhack -- Autonomous -- Analyst

Hi guys. I wanted to ask you another one about the ValuePenguin deal. You mentioned that it would have been high on QuoteWizard's list independent of the acquisition. Is the SEO capability there something that you thought you needed or more of a good opportunity that just presented itself?

J.D. Moriarty -- Chief Financial Officer

We have -- obviously with Magnify and Deposit adding to SEO and diversifying our marketing mix has been a strategic priority for several years now. Insurance is a big category. ValuePenguin is an extraordinary business and high-quality content. It would have taken us years to build that out and so it did present itself.

Do I think we would -- I don't think we would have added it independent of QuoteWizard. As I said big category. We want an end-to-end business and -- the combination enables us to make ValuePenguin even better.

ValuePenguin is a high-margin business to begin with. So, independent of QuoteWizard do I think we would have done ValuePenguin? Probably not. We prioritize businesses that we know we can make better. And having QuoteWizard in the fold having the monetization of QuoteWizard enabled us to execute ValuePenguin and see an upside scenario that was pretty hard to deny.

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

And I would only just accentuate two things. One J.D. hit on the SEO aspect. In an SEO business, you either have to grow it very, very slowly over like almost a decade or you have to buy your way into it because it takes a long time to earn your reputation inside of Google. And so that's -- so we were able to buy our way into that. Then the second thing that J.D. hit on because we knew we had the QuoteWizard monetization, we could already value in the synergy of just moving from their other outlet to something inside of our own platform and so we could see the numbers before we even got them.

Robert Wildhack -- Autonomous -- Analyst

Got it, got it. Thanks. And then on My LendingTree competitively there's obviously Credit Karma but it also seems like a bunch of other consumer finance business is trying to build captive platforms or ecosystems. So what does that look like competitively? And what's the propensity for consumers to sign up and be active on more than one of these platforms?

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

The second question is one that we're actually looking at now. We think it will -- there could actually be a lot of switching and you could have -- and you could be on multiple. But I want to get more data there before we tell you that. However, one good thing about the My LendingTree logged-in experience, we never went down this like free credit report only or led message where it's just like, hey, free credit report. We really have been talking to consumers about we're going to alert you to save your money and improve your credit across all of the products, all of the financial products in your life. And it's working very well.

In addition to that, we're also working on a number of features right now, which I can't let out of the bag but that would differentiate us even more than our other competitors. The key on that is to obviously make sure the consumer experience is great, but obviously also that our monetization is there so that we can go and market it. And we've -- based on the data that we're seeing, where we're seeing consumers coming back, five, six, seven, eight times over a year and improving their credit score and saving like significant amounts of money like, it's a product that just works incredibly well. And I think because we started off in the alert space, because we were tied into all those lenders, I think we've got an advantage but it's definitely warfare. But by the way, keep in mind there too, the LendingTree brand, we haven't talked about this in a number of years, but the LendingTree brand naturally polls better in advertising than other companies' brands. And so as we get the marketing message right in off-line, it's balanced up with online with great content that the consumer is seeing we start to surround them with all of those.

J.D. Moriarty -- Chief Financial Officer

It's a good -- listen, it's a good question on My LendingTree. And as Doug said, like we're not -- when we think about growing that membership base in an environment where that free credit score is a commodity, we want to offer the consumer something different but we're being judicious about how we're going about expanding our base. So last year we talked about our partnership with H&R Block. And Doug referenced the fact that we've got a number of other partnership-oriented deals in the works and those get announced every now and again. Sometimes we have partners who don't want them as broadly announced. But that is how we're going about growing our base of My LendingTree consumers in a very cost-conscious way. And we think we can grow it through these partnerships and add real value for the consumer. But we're very conscious of the fact that the free credit score itself, if that's all you're offering, that you're not offering the consumer very much and you shouldn't pay to get those consumers.

Robert Wildhack -- Autonomous -- Analyst

Got it. Thank you.

Operator

Thank you. And our next question comes from the line of Kunal Madhukar with Deutsche Bank. Your line is open. Please go ahead.

Kunal Madhukar -- Deutsche Bank -- Analyst

Hi. Thanks for taking my questions. A couple if I may. One with regard to the revenue growth in 4Q, how much was that on a pro forma basis? And as you look to the 2019 outlook, based on the guide, what is the pro forma growth that you're projecting?

J.D. Moriarty -- Chief Financial Officer

I'm sorry. Specifically you're referring to total revenue growth pro forma. You mean ex-insurance?

Kunal Madhukar -- Deutsche Bank -- Analyst

Ex all the acquisitions, so that's a number that you typically give out in the Q-over-Q, but what...

J.D. Moriarty -- Chief Financial Officer

Sure. So in Q4 specifically, I'll get that number for you. One second. I mean...

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

And while they're looking for this, the challenge on this, keep in mind, for example, in the card space and we talked about this a number of quarters ago, so it's tough to sort of strip out an acquisition particularly once it's signed. So, for example, when we bought CompareCards at that time we had a LendingTree credit card business and we still do. But increasingly the traffic is going over to the CompareCards network because of higher payouts, deeper coverage and we're merging those two networks. So you're intentionally taking down your revenue on the LendingTree side and putting it over into the CompareCards side. So you just have to be careful with the numbers.

Kunal Madhukar -- Deutsche Bank -- Analyst

Okay then. And the other one was -- and I went back and I looked at the 3Q transcript. And you've definitely been -- when you talked about advertising sales to third parties, you have not said onetime. You said periodic. So in the 2019 outlook, is there any sales for advertising to third parties included in the guide?

J.D. Moriarty -- Chief Financial Officer

Yes, pretty modest though, yes. But, yes, it would be -- it's in other but it's pretty modest. That's not the strategy the third-party sales.

Kunal Madhukar -- Deutsche Bank -- Analyst

Cool. Thank you.

J.D. Moriarty -- Chief Financial Officer

Thanks.

Operator

Our next question comes from the line of Eric Wasserstrom with UBS. Your line is open. Please go ahead.

Eric Wasserstrom -- UBS -- Analyst

Hey, thanks very much. Doug, going back maybe three or four years, I think it was maybe your 2016 Investor Day, you laid out a fairly clear game plan about the verticals in which you were interested in expanding both organically, inorganically. And so fast forward, the QuoteWizard seemed to fill in the last one of those that was sort of significant outstanding, which was insurance of course. And so, I guess, I was surprised to see the ValuePenguin acquisition come subsequently. So can you maybe update us a bit on what you view as the strategic priorities around where there might be gaps in either technology or in product or something and help us understand the priority of organic versus inorganic growth in those areas?

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

So you probably won't like my entire answer, but I would like to think that's not necessarily an either/or. I remember going all the way back to when we first brought J.D. in on corporate development and a lot of people on our team said, well, why do we need somebody who's so senior in corporate development? We don't even have any money. And so we can go get money if we need to. So we definitely go through a very rigorous prioritization process and we look at everything. And it's really prioritizing in term -- I mean you have to look at what are the likely returns, obviously, what are the strategic synergies, but what we like to do I think generally are these more bolt-on-ish like things. Other areas -- so one, for example, we just did which -- or not just, but it's deposits. And we're starting to get really good growth from deposits and you could see yourself scaling into that. I mean we've got a very, very, very small deposit business compared to our competitors and so there's a ton of room to grow there.

And I think you could always look at something in -- I would love to build something around auto. That's a much better consumer experience. I think there are other things out there whether you do that through acquisition or building. And by the way we look both at building internally and we do a lot of building internally and it's really just, which one has the highest return. And that's the way we look at it all, but obviously through a strategic lens as well.

But ValuePenguin, for example, was a no-brainer because it brought in more great content another brand that we can leverage and we knew that the monetization was going to be there because of QuoteWizard.

J.D. Moriarty -- Chief Financial Officer

And Eric, the only thing I would add to that is the question we get often is like what -- maybe it's part of your question what category have we not yet filled in? And one that we've identified -- there are probably two that we identified. But one is on the asset side. And I think our Deposits acquisition highlights that, right?

So we've seen that it's pretty valuable to get on the asset side of the consumer's balance sheet with Deposits and we think we can do that in investment products. And there are a number of promising companies in that space. And so that's a strategic area of interest for us. There's also a lot of interesting things going on in the real estate vertical, and so we're taking a look at that as well.

Now another part of your question was product in tech right? When you look at the acquisitions we've made, they've all been people who are in the same business we're in, albeit in some cases more SEO-oriented. Our SEO strategic initiative was because we knew that we were under-indexed there from a marketing perspective. And the combination of Magnify Deposit and now ValuePenguin, we feel like we've built and will continue to build organically an SEO business. But I would not anticipate more SEO-oriented acquisitions, OK?

We feel like we've achieved that strategic objective. We do get the question on product in tech. And I think that it's possible that our corporate development initiatives could shift more in that direction going forward because absent the two areas that I highlighted meaning investments and real estate there are not other areas within financial services that we need to fill out. Insurance was a clear need given the size of the end market.

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

And just to add on the tech side, in mortgage for example you could -- you think about all the technology that lenders need to run a successful online operation whether it's a CRM system specifically tied for mortgage whether it's pricing engines, automatic applications et cetera, et cetera, et cetera. So some of that technology where you could bring it in standardize it and work with getting it out to your lenders that's something that we've always thought about.

And then the question there is lots of lenders are doing this already, so maybe you don't need to move into a space, which our return might get commoditized. But that's an area we would be looking as well.

Eric Wasserstrom -- UBS -- Analyst

Great. And then if I could just follow-up. I mean I guess what I'm ultimately trying to discern is on the one hand the recent drivers of guidance upside have come largely from acquisition integration. And at the same time it looks like within the core business there's an increase in marketing and acquisition costs.

And so I guess what I'm trying to understand is has there been some change here wherein organic growth is just becoming more challenging and therefore more expensive to accomplish? And is that some indication of kind of the go-forward economics of LendingTree's business?

Douglas Lebda -- Chairman, Chief Executive Officer, and Founder

Yes let me answer it in general and then J.D. can finish in specifics. We have been -- so last year throughout the year we were really again optimizing the business for VMM, but a lot of that meant you can't invest in marketing. So the fact that we are now able to spend in marketing I think as I said before is a very, very good indication and plus then you put My LendingTree on the back of it, which is adding more recurring revenue stream. So I actually think the health of the business looks better going forward. The not -- in areas that we bought in -- we've had to buy in, in verticals basically where we didn't have a presence. And it's a lot -- these guys have been at it for 10-plus years and we could see a lot of synergies. So it was really buying into the categories that we weren't in.

J.D. Moriarty -- Chief Financial Officer

Yeah. I guess I would just -- Eric I'd say you've got some noise in terms of individual products, right? You've got a mortgage business that went through a rising rate environment and you've got a card business that was growing like crazy with balance transfer cards through 2016 and 2017 and had a different environment for 2018.

But if you look at our core business, I guess I'd point back to -- at the end of the day from a margin perspective you've got two things going on in our implied guide in Q1. One, is more spend, which is affecting VMM. We've talked about VMM being in the range of low 30s to high 30s and our guide reflects mid-30s. So that's on the VMM side.

So if we're able to spend on off-line and brand, and go through in the quarter the rebasing of our OpEx, which again that should stabilize that's -- that OpEx lift by the way is very similar to previous Q4 to Q1 periods.

So I don't think it's something endemic to our business. I think you're just seeing two particular businesses in mortgage and card that are going -- that have gone through more challenging environments and it creates a little bit of noise there. At the end of the day when we look at how we're going to manage the business, we're going to manage it for going after VMD right and the opportunities there. And I guess I would just point you to what our market share opportunity is in each of those products. We're still in the early days in penetrating card. We're still in the early days in virtually all of our products in terms of the market share we can garner.

Eric Wasserstrom -- UBS -- Analyst

Thanks so much.

Operator

Thank you. And our next question comes from the line of Youssef Squali with SunTrust. Your line is open. Please go ahead.

Youssef Squali -- SunTrust -- Analyst

Thank you very much. Two areas where you guys had made some smaller acquisitions you did not highlight as potential areas of growth were the credit repair and student loans. Just would love to get an update there, and since those businesses are still subscale what's the strategy there?

And then J.D. just to clarify something you said earlier about the mortgage growth in 2019. I think you talked about negative 5% to 15%. Is that post the slight improvement in the rate environment? Or are you seeing that was the initial thinking coming out of Analyst Day and that thinking has improved since then? Thanks.

J.D. Moriarty -- Chief Financial Officer

Yeah, sure. So let me take the second question first. We gave a guide for the full year at our Investor Day. We've not changed that guide for the given product. We're just changing our -- we're obviously updating our guide for ValuePenguin. We're not changing that guide specifically for mortgage.

That guide was reflective of the fact that the year-over-year comparison includes a very good Q1 of 2017 so a very difficult comp. And that was the discussion we had at the Investor Day. So no there's no change to that thought process. Obviously we've got a better macro environment, in which to execute versus that guide, OK?

The first part of your question was student -- oh, yeah,

Monday, February 25, 2019

This Chart Shows the Next Recession Could Hit in November 2020

This site uses Akismet to reduce spam. Learn how your comment data is processed.

According to one of the best predictors we have, the next recession could start as early as November 2020.

You've likely heard all about the "yield curve" in the financial media. In fact, we've talked a lot about a yield curve inversion here at Money Morning. In short, an inverted yield curve is when the 10-year Treasury yield falls below the two-year Treasury yield, and it's one of the best predictors of a recession we have.

In a healthy economy, the 10-year yield should always be higher since investors have to wait longer for it to mature. That's why it's a very bad sign when the 10-year yield drops below the two-year yield.

A recession has followed every time that's happened.

You Must Act Now: America is headed for an economic disaster bigger than anything since the Great Depression. If you lost out when the markets crashed in 2008, then you are going to want to see this special presentation…

But while you know a recession has followed every yield curve inversion, you might not know how long it takes to happen.

And since that could happen soon, we wanted to make sure you knew exactly what to expect…

Here's When a Recession Starts

Join the conversation. Click here to jump to comments…

Sunday, February 24, 2019

CONSOL Coal Resources (CCR) Lowered to “Hold” at Zacks Investment Research

CONSOL Coal Resources (NYSE:CCR) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Wednesday.

According to Zacks, “CONSOL Coal Resources LP manages and develops active thermal coal operations. The company engages in underground mines and related infrastructure that produce high- BTU bituminuous thermal coal. It primarily sells its coal to electric utilities in the United States. CONSOL Coal Resources LP, formerly known as CNX Coal Resrcs, is based in Canonsburg, Pennsylvania. “

Get CONSOL Coal Resources alerts:

A number of other equities analysts also recently commented on CCR. Citigroup lifted their target price on shares of CONSOL Coal Resources from $16.00 to $19.00 and gave the stock a “neutral” rating in a research note on Friday, November 2nd. ValuEngine downgraded shares of CONSOL Coal Resources from a “buy” rating to a “hold” rating in a research note on Thursday, November 15th. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $20.33.

Shares of CCR stock opened at $18.49 on Wednesday. The company has a current ratio of 0.63, a quick ratio of 0.45 and a debt-to-equity ratio of 0.75. CONSOL Coal Resources has a 12 month low of $13.40 and a 12 month high of $21.13. The stock has a market cap of $500.90 million, a price-to-earnings ratio of 7.68 and a beta of 1.01.

Institutional investors and hedge funds have recently made changes to their positions in the business. Barclays PLC acquired a new stake in shares of CONSOL Coal Resources during the fourth quarter valued at about $34,000. Cypress Capital Management LLC WY increased its position in shares of CONSOL Coal Resources by 170.6% during the fourth quarter. Cypress Capital Management LLC WY now owns 3,098 shares of the energy company’s stock valued at $51,000 after acquiring an additional 1,953 shares during the last quarter. Macquarie Group Ltd. acquired a new stake in shares of CONSOL Coal Resources during the fourth quarter valued at about $116,000. Acadian Asset Management LLC acquired a new stake in shares of CONSOL Coal Resources during the fourth quarter valued at about $176,000. Finally, Geode Capital Management LLC acquired a new stake in shares of CONSOL Coal Resources during the fourth quarter valued at about $611,000. Institutional investors and hedge funds own 23.13% of the company’s stock.

CONSOL Coal Resources Company Profile

CONSOL Coal Resources LP produces and sells high-Btu thermal coal in the Northern Appalachian Basin and the eastern United States. It owns a 25% undivided interest in the Pennsylvania mining complex, which consists of three underground mines and related infrastructure that produce high-Btu bituminous thermal coal located primarily in southwestern Pennsylvania.

Featured Story: What Does Beta Mean In Stock Selection

Get a free copy of the Zacks research report on CONSOL Coal Resources (CCR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Friday, February 22, 2019

Hot Clean Energy Stocks To Own For 2019

tags:MTGE,FIT,PTNR,

The IPO market may not be at the go-go levels of the late 1990s, but the environment is still fairly bullish. This is especially the case with technology companies and biotechs. Note that there have been ten deals that have posted returns of over 100%.

However, by August, the IPO market will essentially close down. This is normal, as many investors will be on vacation.

OK then, so for the next couple weeks, what are the interesting deals that will hit the market? Well, Let’s take a look at five:

IPOs to Watch: Bloom Energy

Bloom Energy, which was founded in 2002, is a high-profile Silicon Valley clean energy operator. The company has built a stationary power generation platform — that relies on natural gas or biogas — for the commercial and industrial (C&I) segments. A system can produce 250 kilowatts of power in half the size of a standard 30-foot shipping container. Customers include biggies like Home Depot (NYSE:HD), AT&T (NYSE:T) and Kaiser Permanente.

Hot Clean Energy Stocks To Own For 2019: American Capital Mortgage Investment Corp.(MTGE)

Advisors' Opinion:
  • [By Max Byerly]

    BidaskClub upgraded shares of MTGE Investment (NASDAQ:MTGE) from a hold rating to a buy rating in a research note published on Thursday.

    A number of other brokerages have also weighed in on MTGE. Keefe, Bruyette & Woods lowered shares of MTGE Investment from an outperform rating to a market perform rating in a research report on Monday, May 7th. Maxim Group lowered shares of MTGE Investment from a buy rating to a hold rating and cut their target price for the company from $21.00 to $19.75 in a research report on Friday, May 4th. Finally, ValuEngine lowered shares of MTGE Investment from a buy rating to a hold rating in a research report on Wednesday, May 2nd.

Hot Clean Energy Stocks To Own For 2019: Fitbit, Inc.(FIT)

Advisors' Opinion:
  • [By ]

    Fitbit(NYSE: FIT), which lost its crown to Apple last year, continues to lose market share due to waning demand for basic and midrange fitness trackers. It was also the only market leader to post a year-over-year drop in shipments. However, IDC said that Fitbit's Versa smartwatch was still the world's "second largest smartwatch brand" with 1.1 million units shipped.

  • [By Paul Ausick]

    Competitors like Fitbit Inc. (NYSE: FIT), Garmin Ltd. (NASDAQ: GRMN) and Alphabet Inc. (NASDAQ: GOOGL), with its Wear OS, are also expected to gain more traction through the forecast period.

  • [By Brian Withers]

    Just when Fitbit (NYSE:FIT) investors were hoping for a glimmer of good news in the company's fourth quarter earnings report, it seems this wearable device maker's turnaround has stalled.

Hot Clean Energy Stocks To Own For 2019: Partner Communications Company Ltd.(PTNR)

Advisors' Opinion:
  • [By Lisa Levin]

    Thursday morning, the telecommunication services shares rose 1.06 percent. Meanwhile, top gainers in the sector included Globalstar, Inc. (NYSE: GSAT), up 5 percent, and Partner Communications Company Ltd. (NASDAQ: PTNR) up 4 percent.

  • [By Stephan Byrd]

    Partner Communications (NASDAQ: PTNR) and Cellcom Israel (NYSE:CEL) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, profitability and dividends.

  • [By Motley Fool Transcribers]

    Partner Communications Company Ltd. (NASDAQ:PTNR)Q2 2018 Earnings Conference CallAug. 15, 2018, 10:00 a.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

  • [By Max Byerly]

    Partner Communications (NASDAQ: PTNR) and Deutsche Telekom (OTCMKTS:DTEGY) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends.

  • [By Money Morning News Team]

    Partner Communications Co. Ltd. (Nasdaq: PTNR) is an Israeli-based mobile network operator, as well as an Internet and telephone provider. Founded in 1999, Partner was formerly operating under the umbrella of the French telecommunications company "Orange" until 2016.

  • [By Lisa Levin]

    Thursday afternoon, the health care shares rose 1.79 percent. Meanwhile, top gainers in the sector included Partner Communications Company Ltd. (NASDAQ: PTNR), up 8 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 7 percent.

Thursday, February 21, 2019

Stocks in the news: PNB, Union Bank, JSW Steel, Tata Steel, Dynamatic Tech, Zuari Agro

Here are stocks that are in the news today:

Results on February 21: Anik Industries, Gopal Iron & Steels

PSU Banks: Government to infuse Rs 48,239 crore in 12 PSU banks - Rs 6,896 crore in Allahabad Bank, Rs 9,086 crore in Corporation Bank, Rs 4,638 crore in Bank Of India, Rs 205 crore in Bank of Maharashtra, Rs 5,908 crore in PNB, Rs 4,112 crore in Union Bank, Rs 3,256 crore in Andhra Bank, Rs 1,603 crore in Syndicate Bank, Rs 2,560 crore in Central Bank Of India, Rs 2,839 crore in United Bank, Rs 3,330 crore in UCO Bank and Rs 3,806 crore in Indian Overseas Bank

IL&FS Financial Services: Company is unable to service obligation on interest payment of NCDs worth Rs 4.2 crore.

related news Stocks in the news: Essel Propack, Duke Offshore, Majesco, Vyapar Industries, Valecha Engg Stocks in the news: Cipla, Tata Steel, Grasim, Ambuja Cements, Huhtamaki PPL, Gokaldas Exports Stocks in the news: Dr Reddy's Labs, Tech Mahindra, Yes Bank, Jaypee Infratech, Wipro

Steel: Government extends exemption on some imported grades of steel until April 17, 2019.

JSW Steel: Moody's changes company's outlook to positive; affirms all ratings.

Yes Bank: Moody's affirms bank's ratings; outlook changed to stable from negative.

Innovative Ideals & Services India: Company has bagged a new order for FTTH & Video Door Phones for supplying & executing for EPSILON Tower, SD CORP, Shapoorji Pallonji group. The value of the order is Rs 1 crore which is expected to be completed by the end of this year.

Diligent Media Corporation: With a view to optimise cost and cut-down losses, the management has decided to suspend publication & distribution of Jaipur Edition of DNA.

Dynamatic Technologies: Company has signed a Memorandum of Understanding with Joint-Stock Company (JSC) Russian Helicopters on Ka-226T Helicopter with an intent to build.

Zuari Agro Chemicals: Board approved raising of funds by way of issue of compulsory convertible debentures to the existing shareholders of the company on a rights basis up to Rs 500 crore.

Sharon Bio-Medicine: Company has received recovery notice under the Maharashtra Value Added Tax Act amounting to Rs 11.17 crore for the period April 1, 2015 to November 3, 2015 and Rs 2.47 crore for the period April 1, 2011 to March 31, 2012. The liability of the said tax would be addressed in line with the Resolution Plan approved by NCLT and later by NCLAT.

Shipping Corporation of India: Company has given physical delivery of its 1 bulk carrier M V Tamilnadu to its buyer.

Bank of Baroda: Board of directors fixed March 11, 2019 as record date for issuing and allotting equity shares of the bank to the shareholders of Vijaya Bank and Dena Bank.

Jubilant Life Sciences: Company issued commercial papers of Rs 75 crore.

Grasim Industries: Company completed acquisition of the chlor-alkali business of KPR Industries.

Tata Steel: Moody's Investors Service has upgraded company's corporate family rating (CFR) by one notch to Ba2 from Ba3.

BPCL: Company is planning to raise up to Rs 2,000 crore during the current financial year through private placement of unsecured non-convertible debentures subject to market conditions.

Sayaji Hotels: Tourism Finance Corporation of India has withdrawn the name of Sanjay Ahuja, Nominee Director from the board of the company.

REC: Company announced a consent solicitation exercise in relation to certain Senior USD Notes.

Bulk Deals on February 20

Gretex Industries: Meghkumar Mahendrakumar Shah sold 24,000 shares of the company at Rs 9 per share on the NSE.

Gujarat Raffia-Roll: Sanjaykumar Sevantilal Shah sold 27,010 shares of the company at Rs 13.25 per share.

Punj Lloyd: JM Global Equities Private Limited sold 24,00,000 shares of the company at Rs 1.8 per share.

Tara Jewels: Punjab National Bank sold 1,47,458 shares of the company at 50 paise per share.

Tarapur Transformers: Rita Rajkumar Singh sold 1,25,605 shares of the company at Rs 2.85 per share.

Viji Finance: Vijay Kothari sold 4,87,657 shares of the company at 86 paise per share.

(For more bulk deals, click here)

Analyst or Board Meet/Briefings

Metalyst Forgings: Board meeting is scheduled on February 27 to consider the un-audited financial results for the quarter and nine months ended December 2018.

Corporation Bank: Board meeting is scheduled to be held on February 25 to consider raising of capital by way of preferential allotment of equity shares to Government of India to the tune of Rs 9,086 crore.

Rollatainers: Board meeting is scheduled on February 25 to consider the un-audited financial results of the company for the quarter and nine months ended December 2018.

India Home Loan: Extraordinary General Meeting to be held on March 16.

Magma Fincorp: Company's officials will be attending Kotak Institutional Equities — Chasing Growth 2019 conference on February 21 at Mumbai.

Gujarat Gas: Company's officials will be attending Kotak Institutional Equities — Chasing Growth 2019 conference on February 21 at Mumbai.

JMT Auto: Board meeting is scheduled on February 25 to consider the results for the quarter ended December 2018.

United Bank of India: Board meeting is scheduled on February 25 to consider prior intimation for seeking approvals relating to preferential allotment to government.

Rallis India: Company's officials will meet analysts/investors on February 21 and 22.

Thyrocare Technologies: Company's officials will meet representative(s) of Consortium Securities Private Limited on February 22 and Pragya Equities Private Limited on February 27.

Ambuja Cements: Company's officials will meet analysts/investors on February 21.

Zensar Technologies: Company's officials will be attending Kotak Institutional Equities — Chasing Growth 2019 conference on February 21 at Mumbai.

S Chand and Company: Company proposes to meet Indus Capital Partners from Hong Kong on February 21 in New Delhi.

Vakrangee: Analyst/Investor meeting for the company has been scheduled from February 25 to 28 in UK & Europe.

Tamil Nadu Newsprint and Papers: Company's officials will meet HDFC Asset Management Company on February 21.

NIIT: Sapnesh Kumar Lalla, Chief Executive Officer and Kapil Saurabh, Associate Vice-President would be meeting investors in a Non-Deal Roadshow on February 22 in Mumbai.

Great Eastern Shipping: Company's officials will meet Nalanda Capital on February 27.

SRF: Ashish Bharat Ram, Managing Director of the company is meeting certain select investors in the UBS Road Show in London on February 21. First Published on Feb 21, 2019 07:41 am

Wednesday, February 20, 2019

Top 5 Biotech Stocks To Own For 2019

tags:AMGN,ARQL,ALNY,BIIB,

Ascendis Pharma A/S (NASDAQ:ASND) – Leerink Swann issued their FY2020 earnings per share estimates for Ascendis Pharma A/S in a research note issued on Wednesday, August 29th. Leerink Swann analyst J. Schwartz expects that the biotechnology company will post earnings of ($5.49) per share for the year. Leerink Swann currently has a “Market Perform” rating and a $70.00 target price on the stock.

Get Ascendis Pharma A/S alerts:

Ascendis Pharma A/S (NASDAQ:ASND) last posted its earnings results on Wednesday, May 30th. The biotechnology company reported ($1.31) earnings per share for the quarter, missing the consensus estimate of ($0.93) by ($0.38). The firm had revenue of $0.03 million for the quarter, compared to analysts’ expectations of $0.30 million. Ascendis Pharma A/S had a negative net margin of 12,089.94% and a negative return on equity of 64.87%.

Top 5 Biotech Stocks To Own For 2019: Amgen Inc.(AMGN)

Advisors' Opinion:
  • [By Stephan Byrd]

    Cpwm LLC increased its holdings in Amgen, Inc. (NASDAQ:AMGN) by 59.7% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,702 shares of the medical research company’s stock after purchasing an additional 3,253 shares during the period. Cpwm LLC’s holdings in Amgen were worth $1,606,000 at the end of the most recent quarter.

  • [By Chris Lange]

    Amgen Inc. (NASDAQ: AMGN) is expected to release its most recent quarterly results on Thursday. The consensus forecast calls for $3.54 in EPS and $5.74 billion in revenue for the second quarter. Shares traded on Friday's close at $190.60. The consensus price target is $196.10, and the 52-week range is $163.31 to $201.23.

  • [By Todd Campbell]

    Neulasta has been one of Amgen's (NASDAQ:AMGN) crown jewels for years, but following FDA approval of Mylan's (NASDAQ:MYL) Neulasta biosimilar this week, Amgen could see Neulasta's revenue slow to a trickle. Is Mylan about to deliver a big blow to Amgen's market share? Read on to find out what's at stake for these companies and their investors.

  • [By Cory Renauer]

    There's a lot for investors to like about Amgen Inc. (NASDAQ:AMGN) and Biogen Inc. (NASDAQ:BIIB). Both of these biotech stocks have produced tremendous returns over the past couple of decades, and the businesses they represent still generate enormous profits. 

  • [By Todd Campbell, Chris Neiger, and Sean Williams]

    Whirlpool Corporation (NYSE:WHR), Amgen Inc. (NASDAQ:AMGN), and Microsoft Corporation (NASDAQ:MSFT) are very different companies, but they all share one thing in common: Our Motley Fool contributors think now's a good time to add them to dividend portfolios. What makes these companies special? Read on to learn why Whirlpool could be a bargain-bin buy because of tariffs, Amgen could benefit from dividend growth thanks to new drugs, and Microsoft's big bet on the cloud makes it a savvy buy.

Top 5 Biotech Stocks To Own For 2019: ArQule Inc.(ARQL)

Advisors' Opinion:
  • [By Joseph Griffin]

    Shares of ArQule, Inc. (NASDAQ:ARQL) were down 5.4% during trading on Wednesday . The company traded as low as $4.71 and last traded at $4.73. Approximately 3,358,864 shares traded hands during trading, an increase of 289% from the average daily volume of 863,008 shares. The stock had previously closed at $5.00.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on ArQule (ARQL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Maxx Chatsko]

    Shares of development-stage biopharma ArQule (NASDAQ:ARQL) rose nearly 17% today after the company announced two appointments to its management team in two newly created positions. Dr. Marc Schegerin will serve as senior vice president, corporate strategy, communication, and finance. Dr. Shirish Hirani will serve as senior vice president, program management and product planning. 

  • [By Logan Wallace]

    ValuEngine downgraded shares of ArQule (NASDAQ:ARQL) from a strong-buy rating to a buy rating in a research report sent to investors on Saturday.

    Several other brokerages also recently issued reports on ARQL. Zacks Investment Research upgraded shares of ArQule from a hold rating to a buy rating and set a $2.75 target price for the company in a research note on Tuesday, May 8th. B. Riley set a $4.00 target price on shares of ArQule and gave the company a buy rating in a research note on Monday, March 26th. Roth Capital raised their target price on shares of ArQule from $5.00 to $6.00 and gave the company a buy rating in a research note on Tuesday, April 17th. BidaskClub upgraded shares of ArQule from a hold rating to a buy rating in a research note on Saturday, May 19th. Finally, Leerink Swann upgraded shares of ArQule from a market perform rating to an outperform rating in a research note on Thursday, April 5th. One research analyst has rated the stock with a sell rating, six have issued a buy rating and one has issued a strong buy rating to the company. The company has an average rating of Buy and a consensus price target of $5.35.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on ArQule (ARQL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Cory Renauer]

    What's behind these dramatic gains? Read on to find out.

    Company Gain in H1 2018 Market Cap Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) 270% $1.19 billion ArQule, Inc. (NASDAQ:ARQL) 235% $482 million Endocyte, Inc. (NASDAQ:ECYT) 222% $959 million Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) 205% $3.99 billion

    Data source: YCharts.

Top 5 Biotech Stocks To Own For 2019: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors' Opinion:
  • [By Brian Orelli]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) updated investors last month on how the launch of Onpattro, its first drug that was approved to treat transthyretin-mediated amyloidosis (ATTR), was going at the J.P. Morgan Healthcare Conference.

  • [By Keith Speights]

    I wrote three months ago that I viewed Alnylam Pharmaceuticals (NASDAQ:ALNY) stock as a pretty good pick -- but with a couple of qualifications. First, I didn't think that the biotech would generate returns in 2018 nearly as great as it did last year. Second, I thought that there were even better stocks to buy than Alnylam.

  • [By Jim Crumly]

    You would think that when a drug company that's been working for 16 years to develop drugs using a novel therapeutic approach wins its first-ever approval from the U.S. Food and Drug Administration (FDA), confetti would fall from the ceiling and its investors would be celebrating a huge stock gain the next day. That didn't happen this week for shareholders of Alnylam Pharmaceuticals (NASDAQ:ALNY), with shares dropping 6.6% the day after the announcement, and there were two main reasons for that.

  • [By Joseph Griffin]

    BidaskClub lowered shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) from a strong-buy rating to a buy rating in a research report released on Monday.

  • [By Jim Crumly]

    As for individual stocks, shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) fell despite the announcement of its first-ever drug approval, and those of Sysco (NYSE:SYY) rose on earnings.

Top 5 Biotech Stocks To Own For 2019: Biogen Idec Inc(BIIB)

Advisors' Opinion:
  • [By George Budwell]

    Not surprisingly, biotech titans Celgene (NASDAQ:CELG) and Biogen (NASDAQ:BIIB) are among the leaders in this ongoing biopharma revolution. So, with that theme in mind, let's attempt to gauge which of these top biotechs is the more attractive long-term buy for investors right now.

  • [By Chris Lange]

    Short interest in Biogen Inc. (NASDAQ: BIIB) increased to 4.00 million shares from the previous 3.91 million. The stock recently traded at $346.90, within a 52-week range of $249.17 to $388.67.

  • [By Ethan Ryder]

    Russell Investments Group Ltd. boosted its holdings in Biogen (NASDAQ:BIIB) by 40.1% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 183,809 shares of the biotechnology company’s stock after buying an additional 52,654 shares during the period. Russell Investments Group Ltd.’s holdings in Biogen were worth $50,222,000 as of its most recent SEC filing.

  • [By Todd Campbell]

    Unfortunately for investors, June's discovery wasn't exciting enough for Sangamo partners Biogen (NASDAQ:BIIB) and Shire (NASDAQ:SHPG). In 2015, Biogen announced a delay to its beta-thalassemia and sickle-cell disease treatment program with Sangamo. And then Shire, a Sangamo collaboration partner since 2012, walked away from Sangamo's hemophilia program.

  • [By Brian Orelli]

    Data source: Ionis Pharmaceuticals.

    What happened with Ionis Pharmaceuticals this quarter? Revenue increased thanks to $41 million in royalties from Biogen's (NASDAQ:BIIB) sales of Spinraza, up from just $5 million in the year-ago quarter. Because the tiered royalty rates reset each year, the royalties as a percentage of sales will end up being higher in the quarters to come this year. Despite the higher revenue, earnings turned negative on a GAAP (generally accepted accounting principles) basis: Ionis and Akcea Therapeutics (NASDAQ:AKCA) increased spending in preparation for the launch of Tegsedi for hereditary transthyretin amyloidosis (hATTR), and Waylivra for familial chylomicronemia syndrome, a rare disease that causes the buildup of lipids. Ionis is still the majority owner of Akcea, so its financials are incorporated into Ionis' financials. The Food and Drug Administration pushed back its goal for making a decision on the marketing application for Tegsedi (the new brand name for inotersen) to Oct. 6, 2018. Ionis provided additional data analysis that the FDA needs additional time to review. In April, Ionis signed another deal with Biogen to develop antisense drugs for neurological disorders. In the deal, Ionis gets $1 billion up front, including an equity investment, in exchange for Biogen having first choice of neurology targets on which to exclusively collaborate with Ionis. Biogen is paying for everything beyond the initial discovery stage, with Ionis eligible for royalties and milestone payments as the drugs advance.

    Image source: Getty Images.

Tuesday, February 19, 2019

Timicoin (TMC) Price Tops $0.0158

Timicoin (CURRENCY:TMC) traded up 0.5% against the U.S. dollar during the twenty-four hour period ending at 23:00 PM ET on February 16th. One Timicoin coin can now be purchased for $0.0158 or 0.00000434 BTC on major exchanges. During the last seven days, Timicoin has traded 11.6% lower against the U.S. dollar. Timicoin has a market cap of $5.00 million and $1,383.00 worth of Timicoin was traded on exchanges in the last day.

Here is how related cryptocurrencies have performed during the last day:

Get Timicoin alerts: XRP (XRP) traded 0.6% lower against the dollar and now trades at $0.30 or 0.00008280 BTC. Tether (USDT) traded down 0.3% against the dollar and now trades at $1.00 or 0.00027583 BTC. TRON (TRX) traded down 0.5% against the dollar and now trades at $0.0239 or 0.00000658 BTC. Stellar (XLM) traded 1.4% lower against the dollar and now trades at $0.0780 or 0.00002149 BTC. Binance Coin (BNB) traded 2.2% lower against the dollar and now trades at $9.03 or 0.00248750 BTC. Bitcoin SV (BSV) traded down 1.3% against the dollar and now trades at $62.01 or 0.01708062 BTC. NEO (NEO) traded 1.2% lower against the dollar and now trades at $8.15 or 0.00224510 BTC. VeChain (VET) traded 1.4% higher against the dollar and now trades at $0.0041 or 0.00000113 BTC. TrueUSD (TUSD) traded 0.2% lower against the dollar and now trades at $1.01 or 0.00027875 BTC. Holo (HOT) traded 3.5% higher against the dollar and now trades at $0.0013 or 0.00000037 BTC.

About Timicoin

Timicoin’s launch date was September 12th, 2013. Timicoin’s total supply is 317,149,560 coins. Timicoin’s official website is timicoin.io. Timicoin’s official Twitter account is @timihealth. The Reddit community for Timicoin is /r/TimiHealth and the currency’s Github account can be viewed here.

Timicoin Coin Trading

Timicoin can be bought or sold on the following cryptocurrency exchanges: LATOKEN. It is usually not currently possible to buy alternative cryptocurrencies such as Timicoin directly using US dollars. Investors seeking to trade Timicoin should first buy Bitcoin or Ethereum using an exchange that deals in US dollars such as Gemini, GDAX or Coinbase. Investors can then use their newly-acquired Bitcoin or Ethereum to buy Timicoin using one of the aforementioned exchanges.

new TradingView.widget({ “height”: 400, “width”: 650, “symbol”: “TMCUSD”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Monday, February 18, 2019

3 Reasons Canopy Growth Investors Should Brace for More Losses

Canopy Growth (NYSE:CGC) recently reported results for the last three months of 2018, and the beginning of Canada's adult-use program helped the company sell 334% more marijuana than a year earlier. Unfortunately, operating expenses rose much further than sales, plus profit margins in the adult-use market are slimmer than expected.

Thanks to a $5 billion cash injection from Constellation Brands earlier this year, the company can afford the losses, but investors want to know if they'll continue. Here are a few reasons to expect at least several more quarters of operating losses from Canopy Growth.

Dry marijuana flowers next to a huge pile of cash.

Image source: Getty Images.

1. Mail-order marijuana is still going strong

The rollout of recreational marijuana in Canada was a non-event for most of the country's users because buying illicit marijuana has felt nearly legal for a long time. There are dozens of mail-order marijuana shops (MoMs) online that ship through Canada Post, discreetly, and most of them even accept PayPal. Although police can get warrants to inspect packages after they've been delivered, it's rarely worth the trouble. Criminal charges for customers are practically unheard of.

Edibles and concentrates are the two fastest-growing product categories in the U.S., but you can't buy either from licensed retailers in Canada. Of course, there are plenty of MoMs that cater to connoisseurs of both. 

MoMs aren't the only competition that licensed producers and retailers like Canopy Growth have to deal with. There are still plenty of illegal marijuana dispensaries throughout the country, and it doesn't look like they're going anywhere. In New Brunswick, Canopy Growth's potential customers are waltzing right past government-run stores that sell its products and into marijuana dispensaries that don't.

While there are occasional reports about dispensaries getting shut down by authorities, local municipalities that don't want to be seen limiting patients' treatment options rarely take action. When pressed about the issue, though, authorities generally claim that enforcing marijuana laws just aren't an efficient use of limited resources. Whatever the case, Canopy will probably have to compete with a thriving illicit market for the long term.

2. Licensed producers can't compete with MoM

Statistics Canada runs anonymous online surveys that ask people for the size and price of their latest marijuana purchases, illicit or licensed. The average price reported for non-medical marijuana fell to just 7.43 Canadian Dollars ($5.61) per gram in 2017, and that was before companies like Canopy Growth started producing enough cannabis each month to cover the Hudson Bay.

During the three months ended December, Canopy Growth recorded an average selling price per gram of CA$6.96 ($5.25) from recreational sales. That's not necessarily bad, but the company also expensed CA$6.41 ($4.84) in production costs per gram sold.

Canopy Growth also reported a CA$1.45 ($1.09) per-gram expense related to Canada's new cannabis excise tax. This is a big advantage for MoMs and illicit dispensaries that don't pay the federal excise tax or provincial sales taxes.  

The price difference for medical-use patients who want an edible solution is enormous. A 60-capsule bottle of Canopy Growth's flagship brand, Tweed soft-gels, costs CA$226.80 ($171.23) at the Ontario Cannabis Store. The bottle contains just 600 mg of marijuana's active ingredient, which is the amount of THC that patients can buy as gummies or candies for between CA$40 ($30.20) and CA$60 ($45.30) from MoMs and dispensaries.

3. There's no legal weed shortage in Canada

Across the country, licensed retailers are having a tough time keeping their shelves stocked, but that isn't because licensed producers can't keep up. According to Health Canada, retailers sold just 14,379 kg of legal cannabis in December. During the same month, ready-for-sale product in the supply chain rose to 57,914 kg.

Aurora Cannabis (NYSE:ACB) is another giant Canadian producer that lost a lot of money recently, and its earnings call highlighted a possible cause of the perceived adult-use marijuana shortages. Aurora, Canopy Growth, and their peers have licenses to export medical marijuana to countries that pay more per gram. As a result, Aurora isn't providing provinces with more adult-use cannabis than their long-term supply contracts require.

At the end of December, Canopy Growth's inventory was worth CA$185 million ($140 million), or 23% more than three months earlier. Keeping sufficient inventory levels is important, but this much inventory growth during a perceived shortage isn't a good sign. 

Two hands passing money and marijuana to another set of hands in an illegal marijuana transaction.

Image source: Getty Images.

On to Plan B?

Canada's adult-use program isn't going to be the revenue contributor investors hoped for, and that's going to cause Canopy Growth to report more operating losses in the quarters ahead. 

Canopy sold medical marijuana in the EU for CA$13.28 ($10.03) per gram, which suggests the region could become a high-margin revenue stream down the road. Sadly, an international revenue stream is probably a lot further down the road than investors hoped for. International sales reached just CA$2.7 million ($2.04 million) during the quarter ended December, which was just CA$1.7 million ($1.28 million) more than a year ago.

Recently, members of the European Parliament approved a motion for a resolution on cannabis for medicinal purposes. The non-binding resolution will ask member countries to prioritize cannabis research and reconsider domestic laws that prevent its sale. 

While a larger EU market could help Canopy Growth make ends meet, it won't happen fast enough to stop this marijuana producer from bleeding money in the foreseeable future. That makes this stock too risky to even consider right now.